EAM
NUVL

Exome Asset Management’s Nuvalent NUVL Stock Holding History

Exome Asset Management’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,580
Closed -$3.19M – 75
2024
Q4 		$3.19M Buy
40,580
+20,635
+103% +$1.93M 2.39% 18
2024
Q3 		$2.04M Buy
+19,945
New +$1.65M 1.38% 35

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Exome Asset Management's NUVL Position: Q1 2025 in Review

Exome Asset Management sold out of Nuvalent (NUVL) in Q1 2025, closing a stake of 40,580 shares — an estimated $3.19M sold.

Exome Asset Management first reported a position in NUVL in Q3 2024 and held it in 2 quarters. The position peaked at $3.19M in Q4 2024. 205 funds tracked by Wall St. Rank hold NUVL as of Q1 2025.

  • Exome Asset Management reported no remaining Nuvalent position as of Q1 2025 after selling out during the quarter.
  • Exome Asset Management sold 40,580 Nuvalent shares in Q1 2025, an estimated $3.19M.
  • Exome Asset Management first reported a position in Nuvalent in Q3 2024 and held it in 2 quarters.
  • Exome Asset Management's Nuvalent position peaked at $3.19M in Q4 2024.
  • 205 funds tracked by Wall St. Rank held Nuvalent as of Q1 2025.

Based on Exome Asset Management's 13F filing for Q1 2025, filed 15 May 2025.